Sinclair Andrew
Insider CIK 1762451 · SRRA Director · SLNO Director · VRNA Director · ACET Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACET Adicet Bio, Inc. | A Award deriv | 2026-06-21 | 2026-06-23 | 4,200 | — | $0 | 4,200 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | D To issuer deriv | 2026-05-18 | 2026-05-18 | 2,666 | — | $0 | 0 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | D To issuer deriv | 2026-05-18 | 2026-05-18 | 635 | — | $0 | 0 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | D To issuer deriv | 2026-05-18 | 2026-05-18 | 823 | — | $0 | 0 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | D To issuer deriv | 2026-05-18 | 2026-05-18 | 1,333 | — | $0 | 0 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | D To issuer deriv | 2026-05-18 | 2026-05-18 | 2,666 | — | $0 | 0 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | D To issuer deriv | 2026-05-18 | 2026-05-18 | 2,666 | — | $0 | 0 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | D To issuer deriv | 2026-05-18 | 2026-05-18 | 2,124 | — | $0 | 0 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | D To issuer deriv | 2026-05-18 | 2026-05-18 | 10,000 | — | $0 | 0 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | D To issuer | 2026-05-18 | 2026-05-18 | 10,491 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 26,400 | — | $0 | 26,400 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2025-06-11 | 2025-06-13 | 5,900 | — | $0 | 17,700 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award | 2025-06-05 | 2025-06-09 | 3,991 | — | $0 | 10,491 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2024-08-21 | 2024-08-23 | 18,500 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2024-08-21 | 2024-08-23 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2024-08-21 | 2024-08-23 | 8,172 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2024-08-21 | 2024-08-23 | 8,172 | — | $0 | 8,172 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2024-08-21 | 2024-08-23 | 18,500 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2024-08-21 | 2024-08-23 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2024-08-21 | 2024-08-23 | 26,400 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2024-08-21 | 2024-08-23 | 26,400 | — | $0 | 26,400 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2024-08-21 | 2024-08-23 | 28,828 | — | $0 | 28,828 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2024-08-21 | 2024-08-23 | 28,828 | — | $0 | 0 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award | 2024-06-06 | 2024-06-10 | 6,500 | — | $0 | 6,500 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 26,400 | — | $0 | 26,400 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2024-06-05 | 2024-06-07 | 5,900 | — | $0 | 11,800 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2023-08-14 | 2023-08-16 | 8,172 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2023-08-14 | 2023-08-16 | 26,400 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2023-08-14 | 2023-08-16 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2023-08-14 | 2023-08-16 | 18,500 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2023-08-14 | 2023-08-16 | 8,172 | — | $0 | 8,172 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2023-08-14 | 2023-08-16 | 26,400 | — | $0 | 26,400 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2023-08-14 | 2023-08-16 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2023-08-14 | 2023-08-16 | 18,500 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2023-08-14 | 2023-08-16 | 28,828 | — | $0 | 28,828 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2023-08-14 | 2023-08-16 | 28,828 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2023-06-01 | 2023-06-02 | 26,400 | — | $0 | 26,400 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2023-06-01 | 2023-06-02 | 5,900 | — | $0 | 5,900 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2023-05-26 | 2023-05-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2023-05-25 | 2023-05-26 | 2,666 | — | $0 | 2,666 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 1,500 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 6,000 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 6,874 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 871,125 | $45.98 | $40.05M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 1,314,127 | $55.00 | $72.28M | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2022-06-02 | 2022-06-03 | 18,500 | — | $0 | 18,500 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2022-06-01 | 2022-10-14 | 2,666 | — | $0 | 2,666 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy deriv | 2022-03-29 | 2022-03-31 | 7,720,000 | — | $0 | 7,720,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2022-03-29 | 2022-03-31 | 7,720,000 | — | $0 | 18,022,602 | SEC↗ |
| SRRA Sierra Oncology, Inc. | P Buy | 2022-01-31 | 2022-02-01 | 150,000 | $27.00 | $4.05M | 1,314,127 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-28 | 2022-02-01 | 287,471 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-28 | 2022-02-01 | 287,471 | $13.20 | $3.79M | 1,164,127 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2021-12-08 | 2021-12-10 | 500,000 | $14.00 | $7.00M | 2,140,721 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2021-12-08 | 2021-12-13 | 500,000 | $14.00 | $7.00M | 2,115,385 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2021-08-09 | 2021-08-10 | 64,000 | — | $0 | 64,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2021-06-08 | 2021-06-09 | 6,000 | — | $0 | 6,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2021-06-01 | 2021-06-04 | 31,862 | — | $0 | 31,862 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2021-04-30 | 2021-05-04 | 8,172 | — | $0 | 8,172 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2021-04-30 | 2021-05-04 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2021-03-02 | 2021-03-04 | 28,828 | — | $0 | 28,828 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2021-03-02 | 2021-03-16 | 28,828 | — | $0 | 28,828 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2021-01-08 | 2021-01-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2020-06-26 | 2020-07-06 | 3,333,330 | $1.65 | $5.50M | 10,302,602 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2020-06-09 | 2020-06-10 | 6,874 | — | $0 | 6,874 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2020-05-18 | 2020-05-20 | 9,530 | — | $0 | 9,530 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion deriv | 2020-01-29 | 2020-01-31 | 11,500 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion deriv | 2020-01-29 | 2020-02-03 | 11,500 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion | 2020-01-29 | 2020-01-31 | 871,125 | — | $0 | 876,542 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion | 2020-01-29 | 2020-02-03 | 871,240 | — | $0 | 876,656 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2019-11-29 | 2019-12-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2019-10-25 | 2019-10-29 | 2,300,000 | $1.20 | $2.76M | 6,969,272 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2019-06-10 | 2019-06-12 | 13,000 | — | $0 | 13,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy deriv | 2018-12-21 | 2018-12-27 | 4,669,272 | $0.01 | $46.7K | 4,669,272 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2018-12-21 | 2018-12-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2018-12-21 | 2018-12-27 | 4,669,272 | $1.60 | $7.47M | 4,669,272 | SEC↗ |